Terns Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
  • Terns Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -31.3 %, a 5.92% decline year-over-year.
  • Terns Pharmaceuticals, Inc. annual Return On Assets for 2023 was -31.9 %, a 3.24% decline from 2022.
  • Terns Pharmaceuticals, Inc. annual Return On Assets for 2022 was -30.9 %, a 13.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -31.3 -1.75 -5.92% Jul 1, 2024 Sep 30, 2024
Q2 2024 -37.7 -10.8 -40% Apr 1, 2024 Jun 30, 2024
Q1 2024 -33.8 -4.4 -15% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.9 -1 -3.24% Oct 1, 2023 Dec 31, 2023
Q3 2023 -29.6 +5.92 +16.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.9 +6.2 +18.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -29.4 -0.21 -0.72% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.9 -3.61 -13.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -35.5 -7.7 -27.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -29.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -27.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 -27.8 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.